Typhoid Fever: The Battle Within
Uncover the fight against typhoid fever and the body's defense mechanisms.
Salma Srour, Mohamed ElGhazaly, Daniel O’Connor, Malick M Gibani, Thomas C Darton, Andrew J Pollard, Mark O Collins, Daniel Humphreys
― 7 min read
Table of Contents
- How Does Typhoid Fever Happen?
- The Role of Water and Vaccines
- How Typhi Invades the Body
- The Mystery of the Toxin
- The Body's Secret Weapon: The Host Secretome
- APOC3: The Protein Puzzler
- The Drama Inside the Cell
- Lysozyme: The Bacteria Buster
- Students of Infection: CACO2 Cells
- A Closer Look at Lysozyme's Power
- The Sneaky Type 3 Secretion System
- Conclusion: The Ongoing Battle
- Original Source
- Reference Links
Typhoid fever is a serious illness caused by a specific type of bacteria known as Salmonella Enterica Serovar Typhi. Every year, around 11 million people get it, and about 116,800 die from the disease. This illness is especially common in low- and middle-income countries. Typhoid fever can be extremely dangerous, but it is preventable through proper sanitation and vaccination.
How Does Typhoid Fever Happen?
The infection begins when the Typhi bacteria invade the intestines. From there, they can enter the bloodstream without causing any noticeable symptoms at first. This phase is called primary bacteremia. After a short period, the bacteria multiply in the lymphatic tissue, and symptoms like fever and abdominal pain start to appear. In some cases, people can carry the bacteria without showing symptoms, allowing for continued spread to others.
The Role of Water and Vaccines
Controlling typhoid fever largely depends on having clean drinking water and effective vaccines. Unfortunately, issues like limited access to proper diagnostic tools and rising antibiotic resistance make it harder to fight this disease. It’s like trying to enjoy a picnic while being swarmed by pesky ants.
How Typhi Invades the Body
To infect the body, Salmonella uses something called a Type 3 Secretion System. This system helps the bacteria inject special proteins directly into human cells, which allows them to enter and begin their sneaky work. One important protein involved in this process is SipB, which helps form a gateway into the human cell.
Once inside, the bacteria reside within a specialized compartment and express a toxin known as Typhoid Toxin. This toxin can affect how the body feels and responds to the infection. It works by damaging the host's DNA, which can lead to further complications.
The Mystery of the Toxin
What happens in the body once this typhoid toxin is released? Scientists are still figuring that out. It’s known that typhoid toxin can trigger a stress response in cells, causing the release of specific proteins. However, the exact relationship between these proteins and the body’s immune response is still a puzzle.
To learn more, researchers conducted a study where human volunteers were intentionally infected with both a normal strain of Typhi and a strain that lacked the toxin. Surprisingly, those without the toxin experienced more severe symptoms and longer-lasting infections. This suggests that the body’s response to the toxin might actually help limit how long the bacteria can stick around.
The Body's Secret Weapon: The Host Secretome
When humans get infected with typhoid, their bodies begin to produce various proteins in reaction to the virus. Researchers have been studying these proteins, collectively known as the host secretome, to understand how they might defend against the infection. It’s similar to a superhero team coming together to fight off an invasion!
In one study, blood samples from participants showed that when infected with a normal strain of Typhi, the levels of certain proteins increased significantly compared to when they were infected with the toxin-free strain. This hinted that the body's response to the toxin might be a crucial part of fighting off typhoid fever.
APOC3: The Protein Puzzler
One protein that gets a lot of attention is called Apolipoprotein C-III, or APOC3 for short. In simple terms, APOC3 is like a traffic officer that manages lipids in the bloodstream. Researchers noted that this protein seems to be affected by the presence of typhoid toxin. If the bacteria are present, the levels of APOC3 increase, suggesting it might play a role in the immune response.
In laboratory tests, human intestinal cells exposed to typhoid toxin showed increased levels of APOC3 over time, indicating that the cells were responding to the infection. Interestingly, when other cells were treated with a version of the toxin that couldn’t cause damage, APOC3 levels didn't rise. This points to a potential link between APOC3 and the stress caused by the toxin.
The Drama Inside the Cell
When researchers looked more deeply into how APOC3 and other proteins behaved in response to typhoid toxin, they found something interesting. In cultured intestinal cells, the toxin led to DNA damage, which is a bit like a computer crashing due to too many programs running at once. This DNA damage was marked by a protein known as γH2AX, indicating that the cell was under stress.
As the cells struggled with their motherboard (DNA), they began to release more APOC3 into the surrounding environment. This means that the body might try to call for backup when the going gets tough!
Lysozyme: The Bacteria Buster
Another protein of interest is lysozyme, which has a reputation for its ability to fight off bacteria. Think of it like a knight in shining armor, charging into battle. When researchers found that lysozyme levels increased in response to typhoid toxin, it made sense to dig deeper.
They found that lysozyme was produced more in cells treated with the toxin compared to those treated with a harmless version. This indicates that lysozyme has a part to play in the host's defense against typhoid fever.
Students of Infection: CACO2 Cells
To study these proteins further, researchers used a type of human intestinal cell line called CACO2. These cells mimic the behavior of actual intestinal cells and can be manipulated in the lab. When treated with typhoid toxin, these cells showed a clear increase in both APOC3 and lysozyme levels, suggesting that the cells were responding defensively to the infection.
But, as with any story, there are twists and turns. When they assessed whether these proteins could actually fight the bacteria, they found that while lysozyme could damage the Salmonella bacteria, APOC3 didn’t seem to intervene directly in the fight against them. This means APOC3 may just be a marker of the immune response rather than a knight charging into battle.
A Closer Look at Lysozyme's Power
Lysozyme is a well-known defender against bacteria, and researchers wanted to see how it fared against Salmonella. They found that when lysozyme was present, the bacteria could change shape and become more vulnerable. This led to an increase in “spheroplasts,” which are weakened bacterial forms that can’t hold their shape anymore.
Interestingly, when researchers combined lysozyme with another protein, lactoferrin, the effect on Salmonella was even more pronounced. Together, they could make a significant dent in the bacteria's defenses. It’s like Batman teaming up with Robin!
The Sneaky Type 3 Secretion System
When Salmonella infects cells, it uses something called the type 3 secretion system to inject its harmful proteins. This is how it gets itself established within the host. Researchers were curious: does lysozyme interfere with this sneaky process?
Surprisingly, they found that lysozyme could halt the bacteria’s ability to use this system to inject its proteins, effectively blocking its main attack. This is a huge win for the body's defense system, showing that lysozyme isn’t just a spectator—it's an active player in the battle against bacteria.
Conclusion: The Ongoing Battle
In conclusion, typhoid fever remains a serious health issue that challenges the human immune system. The body responds to the typhoid toxin by boosting the production of various proteins like APOC3 and lysozyme. Even though APOC3 may not directly fight the bacteria, its presence indicates that the immune system is gearing up for battle.
Lysozyme, on the other hand, takes the charge against the invading bacteria, weakening them and inhibiting their ability to cause damage. The interaction between Salmonella and the human immune system is a fascinating tale of survival, with twists, turns, and unexpected alliances. As researchers continue to unravel the complexities of this relationship, we gain valuable insights into how to better combat diseases like typhoid fever.
So, let’s hope that science continues to shine a light on these battles and helps us find ways to keep those pesky bacteria at bay!
Original Source
Title: Typhoid toxin of Salmonella Typhi elicits host antimicrobial response during acute typhoid fever
Abstract: Salmonella Typhi secretes typhoid toxin that activates cellular DNA damage responses (DDR) during acute typhoid fever. Human infection challenge studies revealed that the toxin suppresses bacteraemia via unknown mechanisms. By applying proteomics to the plasma of bacteraemic participants, we identified that wild-type toxigenic Salmonella induced release of lysozyme (LYZ) and apolipoprotein C3 (APOC3). Recombinant typhoid toxin or infection with toxigenic Salmonella recapitulate LYZ and APOC3 secretion in cultured cells, which involved ATM/ATR-dependent DDRs and confirmed observations in typhoid fever. LYZ alone inhibited secretion of virulence effector proteins SipB and SopE. LYZ caused loss of Salmonella morphology characterised by spheroplast formation. Spheroplast formation was mediated by LYZ and enhanced by lactoferrin, which was identified by proteomics in participants with typhoid fever. Our findings may indicate that toxin-induced DDRs elicit antimicrobial responses, which suppress Salmonella bacteraemia during typhoid fever.
Authors: Salma Srour, Mohamed ElGhazaly, Daniel O’Connor, Malick M Gibani, Thomas C Darton, Andrew J Pollard, Mark O Collins, Daniel Humphreys
Last Update: 2024-12-17 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.12.13.628371
Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.13.628371.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.